1Alan S Maisel,Vikas Bhalla,Eugene Braunwald.Cardiac biomarkers:a contemporary status report.Nature,2006,3:24-34.
2Anthony S McLean,Stephen J Huang,Mark Salter.Bench-to-bedside review:the value of cardiac biomarkers in the intensive care patient.Critical Care,2008,12:215.
3Kristin T,Alpert J S,White H D,et al.Universal definition of myocar-dial infactio Circulation,2007,116:2634-2653.
5Arakawa N.Relatioship between plasma level of brain natriuretic peptide and myocardial infarct size.Cardiology,1994,85:334-340.
6De Lemos J A.The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.N Engl J Med,2001,345:1014-1021.
7Omland T.N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes.Circulation,2002,106:2913-2918.
8Rebuzzi A G.Icremental prognostic value of serum levels of troponinT and C-reactive Protein on admission in patients with unstable angina pectoris.Am J Cardiol,1998,82:715-719.
9Sabatine M S.Multimarker approsch to risk stratification in non-ST elevation acute coronary syndromes:simulataneous assessment of tro-ponin I,C-restive protein,and B-type natriuretic peptide.Circulation,2002,105:1760-1763.
